Prodrugs
Metabasis Therapeutics Presents Preclinical Data on CS-917 and MB07811 at the American Diabetes Association Meeting
Published in Proteomics Weekly, July 9th, 2007
Metabasis Therapeutics, Inc. (Nasdaq:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by targeting the liver and liver pathways, announced that the Company presented two posters at the 67th scientific sessions of the American Diabetes Association (ADA) in Chicago. The posters, entitled, "MB06322 (CS-917), But Not Metformin, Lowers Blood Glucose by Inhibiting Gluconeogenesis in Zucker Diabetic Fatty Rats," and "MB07811, a Liver-Targeted Prodrug of a Novel Thyroid Hormone Receptor Agonist, Lowers Plasma Cholesterol in Cynomolgus Monkeys as Effectively as Atorvastatin," were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2007-07-09)
More Articles from Proteomics Weekly
- Biochemistry
Researchers achieve first signal on the Cryogenic Maldi-FTMS - Cancer
Frog molecule could provide drug treatment for brain tumors - DNA Research
DOE Joint Genome Institute secures long-term lease on production genomics facility - Heart Disease
Scientists identify proteins involved in heart disease - Immunology
Scientists discover role of enzyme in DNA repair - Mental Retardation
MIT researchers reverse symptoms in mice of leading inherited cause of mental retardation - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
